Biotech Cybersecurity Monitoring: 24/7 Threat Detection & Response
Your Security Tools Are Not Proof Someone Is Watching Your Biotech Network There is a dangerous assumption inside many biotech companies: If the security tools are running, the network is being monitored and it must be secure. That is not necessarily true. Your firewall can be running. Your endpoints can have EDR. Your SIEM can […]
Commercialization Will Expose the Security Operations You Never Built
The most dangerous cybersecurity assumption in a pre-commercial biotech company is that security operations can mature later after the next funding round, regulatory milestone, or first revenue. That thinking is backward. Commercialization does not create cyber risk. It exposes security debt accumulated while the business was moving quickly. The identities, cloud platforms, research systems, contractors, […]
Why Biotech Firms Must Secure Data in Motion and Protect Intellectual Property with DLP
In biotech, intellectual property (IP) isn’t just an asset — it’s the company’s lifeblood. Years of research, millions in funding, and the promise of breakthrough therapies depend on the security of sensitive data. Yet, in today’s digital landscape, that lifeblood is constantly at risk. At Single Point of Contact, we’ve seen firsthand how a single […]
Cyber Threats Facing the Biotech Industry: How to Stay Protected in 2025
The evolving threat landscape in 2025 has forced biotech and life sciences firms to reevaluate their cybersecurity posture. As companies digitize more of their operations from R&D to patient data, they also expand the attack surface available to cybercriminals. While large-scale attacks often make headlines, many biotech firms face daily risks that are just as […]